Home › Trials › NCT05916430
Clinical trial Recruiting at 2 sites Observational Ages 8 Months to 10 Months

Screening infants for autism using eye-tracking technology

Official title: Community-viable Screening for Autism Spectrum Disorder (ASD) in 9-month-old Infants Using Quantitative Eye-tracking Assays of Social Visual Engagement

Run by Emory University · NCT05916430 · Data updated 2026-11-12

This study is testing whether an eye-tracking device can help spot signs of autism and developmental delays in 9-month-old babies during their regular check-ups.

Quick facts

Study typeObservational
Ages8 Months to 10 Months
SexAll
Enrollment2120 (estimated)
SponsorEmory University
Academic / other
Locations2 sites (Atlanta, Georgia and 1 other locations)
StatusRecruiting
StartedFebruary 2, 2023
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedJune 4, 2026
Trial IDNCT05916430 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are generally healthy infants aged 8 to 10 months attending their well-baby visits.

Probably not a fit

Infants with acute illnesses that could affect data collection or those outside the specified age range may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the effectiveness of an eye-tracking device to screen 9-month-old infants for autism spectrum disorder and other developmental delays. During routine well-baby visits, infants will watch videos of children playing while their eye movements are recorded to assess their social engagement. Parents will complete questionnaires about their child's health and development at various intervals. If any developmental concerns arise, further assessments will be conducted by expert clinicians to provide appropriate recommendations.

Why it matters

Potential benefit: If successful, this approach could lead to earlier identification and intervention for infants at risk of autism and developmental delays.

How similar studies have gone: Other studies have shown promise in using eye-tracking technology for developmental screening, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Infants between the chronological ages of 8-10 months
* Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision)
* Participants' parents/caregivers must be able to understand and voluntarily provide written informed consent.

Exclusion Criteria:

\- Children will be excluded if they have signs of acute illness likely to prevent successful or valid data collection (e.g., conjunctivitis affecting vision, current vomiting, or high fever).

Where it's running

  • Children's Healthcare of Atlanta
    Atlanta, Georgia, United States     Recruiting
  • Emory University
    Atlanta, Georgia, United States     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Autism 558Infant Development 27Emory University 2068
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.